GenMark Diagnostics, Inc. (GNMK): Price and Financial Metrics


GenMark Diagnostics, Inc. (GNMK): $24.04

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GNMK Stock Summary

  • Price to trailing twelve month operating cash flow for GNMK is currently 286.43, higher than 98.18% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 10.24, GenMark Diagnostics Inc has a higher such ratio than 82.55% of stocks in our set.
  • Revenue growth over the past 12 months for GenMark Diagnostics Inc comes in at 94.9%, a number that bests 94.47% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to GNMK, based on their financial statements, market capitalization, and price volatility, are DYAI, RDFN, MRAM, ESTC, and CLXT.
  • GNMK's SEC filings can be seen here. And to visit GenMark Diagnostics Inc's official web site, go to www.genmarkdx.com.

GNMK Stock Price Chart Interactive Chart >

Price chart for GNMK

GNMK Price/Volume Stats

Current price $24.04 52-week high $24.25
Prev. close $24.04 52-week low $8.42
Day low $24.03 Volume 3,825,600
Day high $24.06 Avg. volume 2,696,111
50-day MA $21.97 Dividend yield N/A
200-day MA $16.25 Market Cap 1.76B

GenMark Diagnostics, Inc. (GNMK) Company Bio


GenMark Diagnostics, Inc. develops, manufactures, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology in the United States. The company is based in Carlsbad, California.


GNMK Latest News Stream


Event/Time News Detail
Loading, please wait...

GNMK Latest Social Stream


Loading social stream, please wait...

View Full GNMK Social Stream

Latest GNMK News From Around the Web

Below are the latest news stories about GenMark Diagnostics Inc that investors may wish to consider to help them evaluate GNMK as an investment opportunity.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | April 13, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds GNMK, LDKB, PBCT, and CTB Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | April 12, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates CLGX, KSHB, AEGN, GNMK; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / April 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:CoreLogic, Inc. (NYSE: CLGX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to funds managed by Stone Point Capital and Insight Partners for $80.

Yahoo | April 12, 2021

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of GenMark Diagnostics (Nasdaq - GNMK)

BALA CYNWYD, PA / ACCESSWIRE / April 5, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of GenMark Diagnostics ("GenMark" or the "Company") (NASDAQ:GNMK) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by Roche. Under the terms of the agreement, GenMark shareholders will receive only $24.

Yahoo | April 5, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds RMBL, STAY, GNMK, and SLGG Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | April 5, 2021

Read More 'GNMK' Stories Here

GNMK Price Returns

1-mo 0.21%
3-mo 5.72%
6-mo 83.09%
1-year 104.42%
3-year 260.96%
5-year 336.30%
YTD 64.66%
2020 203.53%
2019 -1.03%
2018 16.55%
2017 -65.93%
2016 57.73%

Continue Researching GNMK

Want to see what other sources are saying about GenMark Diagnostics Inc's financials and stock price? Try the links below:

GenMark Diagnostics Inc (GNMK) Stock Price | Nasdaq
GenMark Diagnostics Inc (GNMK) Stock Quote, History and News - Yahoo Finance
GenMark Diagnostics Inc (GNMK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.2199 seconds.